Differences in clinical presentations and disease severity according to the infecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variant in children
Monday, April 25, 2022
1:00 PM – 1:15 PM US MT
Location: Convention Center: 709/711
CE: Enduring CME: 0.25
Publication Number: 3550.1
Ana M. Quintero, Nationwide Children's Hospital, Columbus, OH, United States; Rouba Sayegh, Nationwide Children's Hospital, Columbus, OH, United States; Tori R. Wright, Nationwide Children's Hospital, Dublin, OH, United States; Octavio Ramilo, Nationwide Children's Hospital, Columbus, OH, United States; Amy Leber, The Ohio State University, Columbus, OH, United States; Asuncion Mejias, Nationwide Children's Hospital, Columbus, OH, United States; Huanyu Wang, Nationwide Children's Hospital, Department of Pathology, Columbus, OH, United States
Presenting Author(s)
Ana M. Quintero, MD
Pediatric Infectious Disease Fellow Nationwide Children's Hospital Columbus, Ohio, United States
Participants should be aware of the following financial/non-financial relationships:
Ana M. Quintero, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rouba Sayegh, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tori R. Wright, Bachelor of Science in Applied Science Forensic Science: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Octavio Ramilo, MD: ● Adagio (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Lilly (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee). ● Pfizer (Currently Ongoing) (Products/Services: Consultant, Advisory Committee). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee).
Amy Leber, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Asuncion Mejias, MD, PhD, MsCS: ● Janssen (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Advisory Committee). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Sanofi (Currently Ongoing) (Products/Services: Advisory Committee).
Huanyu Wang, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
